S.No.	Article Title	Conference Type	Presentation Type	Reference	From	To
1	Strategies of computer-aided drug design and development: a new perspective	National	Keynote-address	Skill Development Program, Zoology Dept, Daulat Ram College, September 24, 2024, In Silico Novel Therapeutic Discovery	2024-09-20	2024-09-24
2	Identification of novel lead compounds and repurposing FDA approved drugs as telomerase inhibitors using structure-based drug designing approach and their evaluation using in-vitro and ex-vivo assays	International	Poster	Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 4485	2024-04-05	2024-04-10
3	Computational approaches for the development of cyclin-dependent kinase 1 inhibitors as anti-cancer compounds	International	Poster	AT ESMO Targeted Anticancer Therapies Congress (TAT) 26 - 28 February 2024. Abstract no. 49P, ESMO Open Volume 9, Supplement 1, February 2024, 102278.	2024-02-26	2024-02-28
4	Computational Design and development of Pharmaceuticals against bacterial and viral targets	International	Keynote-address	at International Conference on Antimicrobial Resistance, Novel Drug Discovery and Vaccine Development: Challenges and Opportunities, 10-11 March 2025, at SGT University Gurugram	2025-03-10	2025-03-11
5	Combining Conventional Pharmacophore-guided and Artificial Intelligence-based Virtual Screening for Drug Design and Development	International	Oral/Talk	4th World congress on translational cancer research & Immunotherapy, WCTRI- Feb 10-12, 2025, Mahatama Gandhi University of Medical Science, Jaipur	2025-02-10	2025-02-12
6	Multicomplex-Based Pharmacophore-guided virtual screening, molecular docking, and molecular dynamic simulation studies to Discover Novel Inhibitors Targeting Coronavirus Mpro	International	Oral/Talk	International Conference on Antimicrobial Resistance, Novel Drug Discovery and Vaccine Development: Challenges and Opportunities: Vision 2030 Organised by Research & Development Cell, SGT University, Gurugram	2025-03-10	2025-03-11
7	To disclose common biological signatures and predict therapeutic targets in cervical, uterine, and ovarian cancer by integrated bioinformatics analysis and in-vitro studies	International	Oral/Talk	1. INTERNATIONAL CONFERENCE ON INNOVATIONS IN BIOTECHNOLOGY FOR SUSTAINABILITY (IBS-2024) – November 23-25,2024 Organized by the Jawaharlal Nehru University, New Delhi and the Biotech Research Society, India at New Delhi, India	2024-11-23	2024-11-25
8	Unravelling shared molecular markers and forecast treatment targets for ovarian, uterine, and cervical cancer by combined bioinformatics analysis and in vitro studies	International	Oral/Talk	2. 4th World Congress on translational cancer research & immunotherapy – February 10-12,2025 Organized by the Centre for Cancer Immunotherapy (CCI), Sri Ram Cancer & Superspeciality Center (SRCC), Jaipur, Ichan School of Medicine at Mount Sinai, New York, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, The Hormel Institute, USA	2025-02-10	2025-02-12
9	A Comprehensive Machine Learning Framework for Classifying Target-Specific PARP1 Inhibitors	International	Oral/Talk	4th World Congress on translational cancer research & immunotherapy – February 10-12,2025 Organized by the Centre for Cancer Immunotherapy (CCI), Sri Ram Cancer & Superspeciality Center (SRCC), Jaipur, Ichan School of Medicine at Mount Sinai, New York, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, The Hormel Institute, USA	2025-02-10	2025-02-12